Dr Andy Blackwell has stepped down as executive director of Cambridge Cognition Holdings.

He will remain on the board as non-executive director, effective from 1 July.

Blackwell will continue to support the firm’s scientific teams in the US and the EU.

“Nick Kerton, chief executive of Cambridge Cognition, said: "The board fully supports Andy’s professional development plans and appreciates the new perspectives in science and medical technology that he will continue to bring to the company as part of his ongoing non-executive role."